-
Vanderbilt Innovation Catalyst Fund continues advancing research with new review committee
The Vanderbilt Innovation Catalyst Fund bridges the gap between academic research and real-world applications by supporting projects with commercial and societal potential -
Turning Research into Real-World Impact: CTTC Lunch & Learn Series
Through this series, researchers will gain valuable insights into innovation, intellectual property, commercialization pathways, and the startup landscape—all while balancing their academic careers. See below upcoming events in the series. -
Vanderbilt-Discovered Compound Advances to Phase 1 Clinical Trial as a Promising New Treatment for Schizophrenia
Neumora Therapeutics, Inc. has announced the launch of a Phase 1 clinical study evaluating NMRA-861 in healthy adult participants and adults with stable schizophrenia. -
Connecting Research to Real-World Solutions: Karl Zelik's HeroWear Journey
Karl Zelik, a Vanderbilt biomechanical engineer, turned academic research into HeroWear, a company making soft exosuits that reduce back strain and injuries for workers. HeroWear has grown into a global solution that improves safety, comfort, and quality of life for thousands, showing the power of…